Report Detail

Pharma & Healthcare COVID-19 Impact on Global Filgrastim Market Insights, Forecast to 2026

  • RnM4042240
  • |
  • 15 June, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Filgrastim market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Filgrastim market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Filgrastim market is segmented into
Lyophilized Powder
Others

Segment by Application, the Filgrastim market is segmented into
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Regional and Country-level Analysis
The Filgrastim market is analysed and market size information is provided by regions (countries).
The key regions covered in the Filgrastim market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Filgrastim Market Share Analysis
Filgrastim market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Filgrastim business, the date to enter into the Filgrastim market, Filgrastim product introduction, recent developments, etc.
The major vendors covered:
Amgen
SANDOZ INC
Teva
...


1 Study Coverage

  • 1.1 Filgrastim Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Filgrastim Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Filgrastim Market Size Growth Rate by Type
    • 1.4.2 Lyophilized Powder
    • 1.4.3 Others
  • 1.5 Market by Application
    • 1.5.1 Global Filgrastim Market Size Growth Rate by Application
    • 1.5.2 Solid Tumor
    • 1.5.3 Lymphoma
    • 1.5.4 Kidney Cancer
    • 1.5.5 Lung Disease
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Filgrastim Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Filgrastim Industry
      • 1.6.1.1 Filgrastim Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Filgrastim Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Filgrastim Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Filgrastim Market Size Estimates and Forecasts
    • 2.1.1 Global Filgrastim Revenue 2015-2026
    • 2.1.2 Global Filgrastim Sales 2015-2026
  • 2.2 Filgrastim Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Filgrastim Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Filgrastim Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Filgrastim Competitor Landscape by Players

  • 3.1 Filgrastim Sales by Manufacturers
    • 3.1.1 Filgrastim Sales by Manufacturers (2015-2020)
    • 3.1.2 Filgrastim Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Filgrastim Revenue by Manufacturers
    • 3.2.1 Filgrastim Revenue by Manufacturers (2015-2020)
    • 3.2.2 Filgrastim Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Filgrastim Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Filgrastim Revenue in 2019
    • 3.2.5 Global Filgrastim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Filgrastim Price by Manufacturers
  • 3.4 Filgrastim Manufacturing Base Distribution, Product Types
    • 3.4.1 Filgrastim Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Filgrastim Product Type
    • 3.4.3 Date of International Manufacturers Enter into Filgrastim Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Filgrastim Market Size by Type (2015-2020)
    • 4.1.1 Global Filgrastim Sales by Type (2015-2020)
    • 4.1.2 Global Filgrastim Revenue by Type (2015-2020)
    • 4.1.3 Filgrastim Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Filgrastim Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Filgrastim Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Filgrastim Revenue Forecast by Type (2021-2026)
    • 4.2.3 Filgrastim Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Filgrastim Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Filgrastim Market Size by Application (2015-2020)
    • 5.1.1 Global Filgrastim Sales by Application (2015-2020)
    • 5.1.2 Global Filgrastim Revenue by Application (2015-2020)
    • 5.1.3 Filgrastim Price by Application (2015-2020)
  • 5.2 Filgrastim Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Filgrastim Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Filgrastim Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Filgrastim Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Filgrastim by Country
    • 6.1.1 North America Filgrastim Sales by Country
    • 6.1.2 North America Filgrastim Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Filgrastim Market Facts & Figures by Type
  • 6.3 North America Filgrastim Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Filgrastim by Country
    • 7.1.1 Europe Filgrastim Sales by Country
    • 7.1.2 Europe Filgrastim Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Filgrastim Market Facts & Figures by Type
  • 7.3 Europe Filgrastim Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Filgrastim by Region
    • 8.1.1 Asia Pacific Filgrastim Sales by Region
    • 8.1.2 Asia Pacific Filgrastim Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Filgrastim Market Facts & Figures by Type
  • 8.3 Asia Pacific Filgrastim Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Filgrastim by Country
    • 9.1.1 Latin America Filgrastim Sales by Country
    • 9.1.2 Latin America Filgrastim Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Filgrastim Market Facts & Figures by Type
  • 9.3 Central & South America Filgrastim Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Filgrastim by Country
    • 10.1.1 Middle East and Africa Filgrastim Sales by Country
    • 10.1.2 Middle East and Africa Filgrastim Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Filgrastim Market Facts & Figures by Type
  • 10.3 Middle East and Africa Filgrastim Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Amgen
    • 11.1.1 Amgen Corporation Information
    • 11.1.2 Amgen Description, Business Overview and Total Revenue
    • 11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Amgen Filgrastim Products Offered
    • 11.1.5 Amgen Recent Development
  • 11.2 SANDOZ INC
    • 11.2.1 SANDOZ INC Corporation Information
    • 11.2.2 SANDOZ INC Description, Business Overview and Total Revenue
    • 11.2.3 SANDOZ INC Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 SANDOZ INC Filgrastim Products Offered
    • 11.2.5 SANDOZ INC Recent Development
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Description, Business Overview and Total Revenue
    • 11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva Filgrastim Products Offered
    • 11.3.5 Teva Recent Development
  • 11.1 Amgen
    • 11.1.1 Amgen Corporation Information
    • 11.1.2 Amgen Description, Business Overview and Total Revenue
    • 11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Amgen Filgrastim Products Offered
    • 11.1.5 Amgen Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Filgrastim Market Estimates and Projections by Region
    • 12.1.1 Global Filgrastim Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Filgrastim Revenue Forecast by Regions 2021-2026
  • 12.2 North America Filgrastim Market Size Forecast (2021-2026)
    • 12.2.1 North America: Filgrastim Sales Forecast (2021-2026)
    • 12.2.2 North America: Filgrastim Revenue Forecast (2021-2026)
    • 12.2.3 North America: Filgrastim Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Filgrastim Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Filgrastim Sales Forecast (2021-2026)
    • 12.3.2 Europe: Filgrastim Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Filgrastim Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Filgrastim Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Filgrastim Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Filgrastim Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Filgrastim Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Filgrastim Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Filgrastim Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Filgrastim Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Filgrastim Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Filgrastim Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Filgrastim Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Filgrastim Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Filgrastim Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Filgrastim Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Filgrastim Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Filgrastim. Industry analysis & Market Report on COVID-19 Impact on Global Filgrastim is a syndicated market report, published as COVID-19 Impact on Global Filgrastim Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Filgrastim market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,104.40
    4,656.60
    6,208.80
    3,623.10
    5,434.65
    7,246.20
    600,366.00
    900,549.00
    1,200,732.00
    325,689.00
    488,533.50
    651,378.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report